↓ Cooling
Business
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Novo Nordisk has entered into a partnership with Vivani to develop a long-acting semaglutide implant designed for weight management.
2 trends tracked about this subject — the full history, oldest to newest below.
Novo Nordisk has entered into a partnership with Vivani to develop a long-acting semaglutide implant designed for weight management.
New study data suggests GLP-1 medications like Ozempic and Wegovy may reduce fracture risks and improve bone health in Type 2 diabetes patients.